02Who is involvedEvidence still neededOpen review status ↗
Supported as a missing explanation. Document 0 names no investors, lenders, arrangers, or Series A roles.
03What happenedEvidence still neededOpen review status ↗
Supported as a missing explanation. The only September 11, 2026 financing-like item in document 0 is 'Tempest Therapeutics Announces Up to $7.5 Million Private Placement,' not a Series A round. The amount is a private placement amount, not a valuation.
04Why it mattersEvidence still neededOpen review status ↗
Supported. Because the supplied document does not establish a Series A event, Series A-specific business significance cannot be grounded. Any relevance interpretation would need to be limited to the private placement or the company's CAR-T business, not the target Series A.
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Tempest Therapeutics · Financing Record
Explore source-linked visual explanations for Tempest Therapeutics. Unsupported claims are withheld while source review continues.